TabsDetailsBasic DetailsDate: Thursday, January 19, 2012Type: PublicationDescription: This article describes the creation of the Postlicensure Rapid Immunization Safety Monitoring (PRISM) program, which used data from national health insurance plans and immunization registries to monitor the safety of the H1N1 influenza vaccine, and the integration of PRISM into the FDA's Mini-Sentinel pilot program. Read More Materials: Pharmacoepidemiology and Drug Safety, Volume 21, Issue Supplement S1, January 2012, Pages 291-297, DOI: 10.1002/pds.2323Additional InformationRelated Assessment(s): PDS Supplement: The U.S. Food and Drug Administration's Mini-Sentinel ProgramContributorsAuthor(s): Michael Nguyen MD; Robert Ball MD, MPH, ScM; Karen Midthun MD; Tracy A. Lieu MD, MPHCorresponding Author: M. Nguyen, Center for Biologics Evaluation and Research, FDA, Silver Spring, MD, USA. E-mail: michael.nguyen@fda.hhs.gov
